Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer
Open Access
- 30 May 2017
- journal article
- research article
- Published by Springer Nature in Infectious Agents and Cancer
- Vol. 12 (1) , 1-6
Abstract
The association between Epstein-Barr virus (EBV) and the development of head and neck cancer was reported by many researchers. The aim of the present study was to detect EBV DNA and EBV antibodies in 110 Polish patients with oropharyngeal and laryngeal cancer compared to 40 healthy individuals. Frozen tumor tissue fragments were tested using nested PCR assay for EBV DNA detection. Sera from all individuals were investigated using ELISA tests to detect the presence of VCA IgM and IgG, EBNA IgG, EA IgG. EBV DNA was detected in 52.7% of the patients (25% in controls). EBVCA were detected in 94.5%, EBNA in 96.4% and EA in 94.5% of patients. The significantly higher level of EA in the patients suggests EBV reactivation. The majority of patients (83%) were infected with wild-type EBV. Our study showed that this variant seems to be associated with oropharyngeal and laryngeal cancer in the Polish population.Keywords
Funding Information
- Research Grant from the Medical University, Lublin, Poland (DS 233)
This publication has 39 references indexed in Scilit:
- Role of infectious agents in the carcinogenesis of brain and head and neck cancersInfectious Agents and Cancer, 2013
- Epstein-Barr Virus Sequence Variation—Biology and DiseasePathogens, 2012
- Role of EBNA1 in NPC tumourigenesisSeminars in Cancer Biology, 2012
- Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese childrenVirology Journal, 2012
- Infectious Mononucleosis in University Students in the United Kingdom: Evaluation of the Clinical Features and Consequences of the DiseaseClinical Infectious Diseases, 2010
- Epstein‐Barr virus and the pathogenesis of Burkitt's lymphoma: More questions than answersInternational Journal of Cancer, 2009
- Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: A possible alternative for primary screening of nasopharyngeal carcinomaOral Oncology, 2008
- Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in ThaisJournal of Clinical Virology, 2008
- Various 30 and 69bp deletion variants of the Epstein-Barr virus LMP1 may arise by homologous recombination in nasopharyngeal carcinoma of Tunisian patientsVirus Research, 2006
- Epstein–Barr virus: 40 years onNature Reviews Cancer, 2004